香港股市 已收市

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
359.18-13.47 (-3.61%)
收市價: 04:00PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價372.65
開市370.74
買盤346.95 x 1300
賣出價349.00 x 1200
今日波幅345.00 - 370.80
52 週波幅58.81 - 464.00
成交量5,547,235
平均成交量4,135,684
市值87.107B
Beta 值 (5 年,每月)
市盈率 (最近 12 個月)19.76
每股盈利 (最近 12 個月)18.18
業績公佈日2021年11月09日
遠期股息及收益率無 (無)
除息日
1 年預測目標價334.31
  • Bloomberg

    美國FDA顧問小組投票反對輝瑞-BioNTech的新冠疫苗加強針

    【彭博】-- 輝瑞股價聞訊擴大跌勢。失去美國食品藥品管理局(FDA)顧問小組的支持令拜登的加強針計畫受到打擊原文標題FDA Advisers Vote Against Pfizer-BioNTech Booster ShotMore stories like this are available on bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Yahoo Finance

    FDA panel votes for Pfizer's booster shot for high risk, ages 65+

    A U.S. Food and Drug Administration (FDA) advisory panel voted Fridayto approve Pfizer/BioNTech's third dose for U.S. residents aged 65 and older, as well as high risk individuals.

  • Benzinga

    British Study To Test Mixed COVID-19 Vaccine Regime In Kids: Reuters

    A British study will be launched to assess the mixed COVID-19 vaccine shots in children, Reuters reported. The study, called Com-COV3, will test different vaccine schedules in 360 volunteers aged 12 to 16 years, looking at the immune responses and milder side effects. Related Link: UK Outlines COVID-19 Booster Shot Plan: What You Need To Know. Children aged 12-15 in Britain will be vaccinated from next week, while those aged 16-17 have been eligible for shots since August. Children will be offer